1. Home
  2. Pharma & Healthcare
  3. Global and Japan In Vitro Diagnostic/IVD Market 2020 by Company, Type and Application, Forecast to 2025

Global and Japan In Vitro Diagnostic/IVD Market 2020 by Company, Type and Application, Forecast to 2025

Publication Month: Feb 2020 | No. of Pages: 92 Published By: Global Info Research
Single User License: US $ 3980
Corporate User License: US $ 7960

Market Overview
The global In Vitro Diagnostic/IVD market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The In Vitro Diagnostic/IVD market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
In Vitro Diagnostic/IVD market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, In Vitro Diagnostic/IVD market has been segmented into Instruments, Reagents, etc.

Breakdown by Application, In Vitro Diagnostic/IVD has been segmented into Diabetes, Oncology, Cardiology, Nephrology, etc.

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global In Vitro Diagnostic/IVD market presented in the report. This section sheds light on the sales growth of different regional and country-level In Vitro Diagnostic/IVD markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global In Vitro Diagnostic/IVD market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and In Vitro Diagnostic/IVD Market Share Analysis
In Vitro Diagnostic/IVD competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, In Vitro Diagnostic/IVD revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the In Vitro Diagnostic/IVD revenue and market share for each player covered in this report.

The major players covered in In Vitro Diagnostic/IVD are: Roche Diagnostics (Switzerland), Sysmex Corporation (Japan), Abbott Laboratories (US), Siemens Healthineers (Germany), Bio-Rad Laboratories (US), Danaher Corporation (US), DiaSorin (Italy), Johnson and Johnson (US), Thermo Fisher Scientific (US), bioMérieux (France), Ortho Clinical Diagnostics (US), Agilent Technologies (US), QIAGEN (Germany), etc. Among other players domestic and global, In Vitro Diagnostic/IVD market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers
Roche Diagnostics (Switzerland)
Sysmex Corporation (Japan)
Abbott Laboratories (US)
Siemens Healthineers (Germany)
Bio-Rad Laboratories (US)
Danaher Corporation (US)
DiaSorin (Italy)
Johnson and Johnson (US)
Thermo Fisher Scientific (US)
bioMérieux (France)
Ortho Clinical Diagnostics (US)
Agilent Technologies (US)
QIAGEN (Germany)

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:
Instruments
Reagents

Market segment by Application, can be divided into
Diabetes
Oncology
Cardiology
Nephrology

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of In Vitro Diagnostic/IVD
1.2 Classification of In Vitro Diagnostic/IVD by Type
1.2.1 Overview: Global In Vitro Diagnostic/IVD Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global In Vitro Diagnostic/IVD Revenue Market Share by Type in 2019
1.2.3 Instruments
1.2.4 Reagents
1.3 Global In Vitro Diagnostic/IVD Market by Application
1.3.1 Overview: Global In Vitro Diagnostic/IVD Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Diabetes
1.3.3 Oncology
1.3.4 Cardiology
1.3.5 Nephrology
1.4 Global In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
1.5 Global In Vitro Diagnostic/IVD Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global In Vitro Diagnostic/IVD Market Size by Regions (2015-2020)
1.7 Global In Vitro Diagnostic/IVD Market Size and Forecast by Regions (2020-2025)
1.7.1 North America In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
1.7.2 Europe In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
1.7.3 Asia In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
1.7.4 South America In Vitro Diagnostic/IVD Status and Prospect (2015-2025)
1.7.5 Middle East & Africa In Vitro Diagnostic/IVD Status and Prospect (2015-2025)

2 Company Profiles
2.1 Roche Diagnostics (Switzerland)
2.1.1 Roche Diagnostics (Switzerland) Details
2.1.2 Roche Diagnostics (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche Diagnostics (Switzerland) SWOT Analysis
2.1.4 Roche Diagnostics (Switzerland) Product and Services
2.1.5 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sysmex Corporation (Japan)
2.2.1 Sysmex Corporation (Japan) Details
2.2.2 Sysmex Corporation (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sysmex Corporation (Japan) SWOT Analysis
2.2.4 Sysmex Corporation (Japan) Product and Services
2.2.5 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott Laboratories (US)
2.3.1 Abbott Laboratories (US) Details
2.3.2 Abbott Laboratories (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott Laboratories (US) SWOT Analysis
2.3.4 Abbott Laboratories (US) Product and Services
2.3.5 Abbott Laboratories (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.4 Siemens Healthineers (Germany)
2.4.1 Siemens Healthineers (Germany) Details
2.4.2 Siemens Healthineers (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Siemens Healthineers (Germany) SWOT Analysis
2.4.4 Siemens Healthineers (Germany) Product and Services
2.4.5 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Rad Laboratories (US)
2.5.1 Bio-Rad Laboratories (US) Details
2.5.2 Bio-Rad Laboratories (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bio-Rad Laboratories (US) SWOT Analysis
2.5.4 Bio-Rad Laboratories (US) Product and Services
2.5.5 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.6 Danaher Corporation (US)
2.6.1 Danaher Corporation (US) Details
2.6.2 Danaher Corporation (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Danaher Corporation (US) SWOT Analysis
2.6.4 Danaher Corporation (US) Product and Services
2.6.5 Danaher Corporation (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.7 DiaSorin (Italy)
2.7.1 DiaSorin (Italy) Details
2.7.2 DiaSorin (Italy) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 DiaSorin (Italy) SWOT Analysis
2.7.4 DiaSorin (Italy) Product and Services
2.7.5 DiaSorin (Italy) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson and Johnson (US)
2.8.1 Johnson and Johnson (US) Details
2.8.2 Johnson and Johnson (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson and Johnson (US) SWOT Analysis
2.8.4 Johnson and Johnson (US) Product and Services
2.8.5 Johnson and Johnson (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher Scientific (US)
2.9.1 Thermo Fisher Scientific (US) Details
2.9.2 Thermo Fisher Scientific (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher Scientific (US) SWOT Analysis
2.9.4 Thermo Fisher Scientific (US) Product and Services
2.9.5 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.10 bioMérieux (France)
2.10.1 bioMérieux (France) Details
2.10.2 bioMérieux (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 bioMérieux (France) SWOT Analysis
2.10.4 bioMérieux (France) Product and Services
2.10.5 bioMérieux (France) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ortho Clinical Diagnostics (US)
2.11.1 Ortho Clinical Diagnostics (US) Details
2.11.2 Ortho Clinical Diagnostics (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ortho Clinical Diagnostics (US) SWOT Analysis
2.11.4 Ortho Clinical Diagnostics (US) Product and Services
2.11.5 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.12 Agilent Technologies (US)
2.12.1 Agilent Technologies (US) Details
2.12.2 Agilent Technologies (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Agilent Technologies (US) SWOT Analysis
2.12.4 Agilent Technologies (US) Product and Services
2.12.5 Agilent Technologies (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)
2.13 QIAGEN (Germany)
2.13.1 QIAGEN (Germany) Details
2.13.2 QIAGEN (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 QIAGEN (Germany) SWOT Analysis
2.13.4 QIAGEN (Germany) Product and Services
2.13.5 QIAGEN (Germany) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players
3.1 Global In Vitro Diagnostic/IVD Market Size by Players (2015-2020)
3.2 Japan In Vitro Diagnostic/IVD Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 In Vitro Diagnostic/IVD Players Market Share
3.3.2 Top 10 In Vitro Diagnostic/IVD Players Market Share

4 North America Market Size and Forecast by Countries
4.1 North America In Vitro Diagnostic/IVD Market Size by Countries (2015-2020)
4.2 North America In Vitro Diagnostic/IVD Market Size and Forecast by Countries (2015-2026)
4.3 United States In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
4.4 Canada In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
4.5 Mexico In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries
5.1 Europe In Vitro Diagnostic/IVD Market Size by Countries (2015-2020)
5.2 Europe In Vitro Diagnostic/IVD Market Size and Forecast by Countries (2015-2026)
5.3 Germany In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
5.4 France In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
5.5 UK In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
5.6 Russia In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
5.7 Italy In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific In Vitro Diagnostic/IVD Market Size by Regions (2015-2020)
6.2 Asia-Pacific In Vitro Diagnostic/IVD Market Size and Forecast by Regions (2015-2026)
6.3 China In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
6.4 Japan In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
6.5 Korea In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
6.6 India In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
6.7 Southeast Asia In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries
7.1 South America In Vitro Diagnostic/IVD Market Size by Countries (2015-2020)
7.2 South America In Vitro Diagnostic/IVD Market Size and Forecast by Countries (2015-2026)
7.3 Brazil In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
7.4 Argentina In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa In Vitro Diagnostic/IVD Revenue by Regions (2015-2020)
8.2 Middle East & Africa In Vitro Diagnostic/IVD Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
8.4 UAE In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
8.5 Egypt In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)
8.6 South Africa In Vitro Diagnostic/IVD Market Size and Forecast (2015-2025)

9 Market Size Segment by Type
9.1 Global In Vitro Diagnostic/IVD Market Size and Forecast by Type (2015-2025)
9.1.1 Global In Vitro Diagnostic/IVD Market Size by Type (2015-2020)
9.1.2 Global In Vitro Diagnostic/IVD Market Size Forecast by Type (2020-2025)
9.2 Japan In Vitro Diagnostic/IVD Market Size and Forecast by Type (2015-2025)
9.2.1 Japan In Vitro Diagnostic/IVD Market Size by Type (2015-2020)
9.2.2 Japan In Vitro Diagnostic/IVD Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application
10.1 Global In Vitro Diagnostic/IVD Market Size and Forecast by Application (2015-2025)
10.1.1 Global In Vitro Diagnostic/IVD Market Size by Application (2015-2020)
10.1.2 Global In Vitro Diagnostic/IVD Market Size Forecast by Application (2020-2025)
10.2 Japan In Vitro Diagnostic/IVD Market Size and Forecast by Application (2015-2025)
10.2.1 Japan In Vitro Diagnostic/IVD Market Size by Application (2015-2020)
10.2.2 Japan In Vitro Diagnostic/IVD Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US

Tables and Figures

List of Tables

Table 1. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of In Vitro Diagnostic/IVD by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market In Vitro Diagnostic/IVD Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Regions (2015-2020)
Table 6. Global In Vitro Diagnostic/IVD Revenue Share by Regions (2015-2020)
Table 7. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Regions (2020-2025)
Table 8. Global In Vitro Diagnostic/IVD Revenue Market Share by Regions (2020-2025)
Table 9. Roche Diagnostics (Switzerland) Corporate Information, Location and Competitors
Table 10. Roche Diagnostics (Switzerland) Major Business
Table 11. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 12. Roche Diagnostics (Switzerland) SWOT Analysis
Table 13. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Product and Solutions
Table 14. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Sysmex Corporation (Japan) Corporate Information, Location and Competitors
Table 16. Sysmex Corporation (Japan) Major Business
Table 17. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2018-2019)
Table 18. Sysmex Corporation (Japan) SWOT Analysis
Table 19. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Product and Solutions
Table 20. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Abbott Laboratories (US) Corporate Information, Location and Competitors
Table 22. Abbott Laboratories (US) Major Business
Table 23. Abbott Laboratories (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 24. Abbott Laboratories (US) SWOT Analysis
Table 25. Abbott Laboratories (US) In Vitro Diagnostic/IVD Product and Solutions
Table 26. Abbott Laboratories (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Siemens Healthineers (Germany) Corporate Information, Location and Competitors
Table 28. Siemens Healthineers (Germany) Major Business
Table 29. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 30. Siemens Healthineers (Germany) SWOT Analysis
Table 31. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Product and Solutions
Table 32. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Bio-Rad Laboratories (US) Corporate Information, Location and Competitors
Table 34. Bio-Rad Laboratories (US) Major Business
Table 35. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 36. Bio-Rad Laboratories (US) SWOT Analysis
Table 37. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Product and Solutions
Table 38. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Danaher Corporation (US) Corporate Information, Location and Competitors
Table 40. Danaher Corporation (US) Major Business
Table 41. Danaher Corporation (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 42. Danaher Corporation (US) SWOT Analysis
Table 43. Danaher Corporation (US) In Vitro Diagnostic/IVD Product and Solutions
Table 44. Danaher Corporation (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. DiaSorin (Italy) Corporate Information, Location and Competitors
Table 46. DiaSorin (Italy) Major Business
Table 47. DiaSorin (Italy) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 48. DiaSorin (Italy) SWOT Analysis
Table 49. DiaSorin (Italy) In Vitro Diagnostic/IVD Product and Solutions
Table 50. DiaSorin (Italy) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. Johnson and Johnson (US) Corporate Information, Location and Competitors
Table 52. Johnson and Johnson (US) Major Business
Table 53. Johnson and Johnson (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 54. Johnson and Johnson (US) SWOT Analysis
Table 55. Johnson and Johnson (US) In Vitro Diagnostic/IVD Product and Solutions
Table 56. Johnson and Johnson (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. Thermo Fisher Scientific (US) Corporate Information, Location and Competitors
Table 58. Thermo Fisher Scientific (US) Major Business
Table 59. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 60. Thermo Fisher Scientific (US) SWOT Analysis
Table 61. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Product and Solutions
Table 62. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. bioMérieux (France) Corporate Information, Location and Competitors
Table 64. bioMérieux (France) Major Business
Table 65. bioMérieux (France) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 66. bioMérieux (France) SWOT Analysis
Table 67. bioMérieux (France) In Vitro Diagnostic/IVD Product and Solutions
Table 68. bioMérieux (France) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Ortho Clinical Diagnostics (US) Corporate Information, Location and Competitors
Table 70. Ortho Clinical Diagnostics (US) Major Business
Table 71. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 72. Ortho Clinical Diagnostics (US) SWOT Analysis
Table 73. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Product and Solutions
Table 74. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. Agilent Technologies (US) Corporate Information, Location and Competitors
Table 76. Agilent Technologies (US) Major Business
Table 77. Agilent Technologies (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 78. Agilent Technologies (US) SWOT Analysis
Table 79. Agilent Technologies (US) In Vitro Diagnostic/IVD Product and Solutions
Table 80. Agilent Technologies (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. QIAGEN (Germany) Corporate Information, Location and Competitors
Table 82. QIAGEN (Germany) Major Business
Table 83. QIAGEN (Germany) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)
Table 84. QIAGEN (Germany) SWOT Analysis
Table 85. QIAGEN (Germany) In Vitro Diagnostic/IVD Product and Solutions
Table 86. QIAGEN (Germany) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Players (2015-2020)
Table 88. Global In Vitro Diagnostic/IVD Revenue Share by Players (2015-2020)
Table 89. Key Players In Vitro Diagnostic/IVD Revenue (USD Million) in Japan (2015-2020)
Table 90. Key Players In Vitro Diagnostic/IVD Revenue Share in Japan (2015-2020)
Table 91. North America In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2015-2020)
Table 92. North America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Table 93. North America In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2020-2026)
Table 94. North America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2020-2026)
Table 95. Europe In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2015-2020)
Table 96. Europe In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Table 97. Europe In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2020-2026)
Table 98. Europe In Vitro Diagnostic/IVD Revenue Market Share by Countries (2020-2026)
Table 99. Asia-Pacific In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2015-2020)
Table 100. Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Table 101. Asia-Pacific In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2020-2026)
Table 102. Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Share by Countries (2020-2026)
Table 103. South America In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2015-2020)
Table 104. South America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Table 105. South America In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2020-2026)
Table 106. South America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2020-2026)
Table 107. Middle East & Africa In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2015-2020)
Table 108. Middle East & Africa In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)
Table 109. Middle East & Africa In Vitro Diagnostic/IVD Revenue (USD Million) by Countries (2020-2026)
Table 110. Middle East & Africa In Vitro Diagnostic/IVD Revenue Market Share by Countries (2020-2026)
Table 111. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Type (2015-2020)
Table 112. Global In Vitro Diagnostic/IVD Revenue Share by Type (2015-2020)
Table 113. Global In Vitro Diagnostic/IVD Revenue Forecast by Type (2020-2025)
Table 114. Global In Vitro Diagnostic/IVD Market Share Forecast by Type (2020-2025)
Table 115. Japan In Vitro Diagnostic/IVD Revenue (USD Million) by Type (2015-2020)
Table 116. Japan In Vitro Diagnostic/IVD Revenue Share by Type (2015-2020)
Table 117. Japan In Vitro Diagnostic/IVD Revenue Forecast by Type (2020-2025)
Table 118. Japan In Vitro Diagnostic/IVD Market Share Forecast by Type (2020-2025)
Table 119. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Application (2015-2020)
Table 120. Global In Vitro Diagnostic/IVD Revenue Share by Application (2015-2020)
Table 121. Global In Vitro Diagnostic/IVD Revenue Forecast by Application (2020-2025)
Table 122. Global In Vitro Diagnostic/IVD Market Share Forecast by Application (2020-2025)
Table 123. Japan In Vitro Diagnostic/IVD Revenue (USD Million) by Application (2015-2020)
Table 124. Japan In Vitro Diagnostic/IVD Revenue Share by Application (2015-2020)
Table 125. Japan In Vitro Diagnostic/IVD Revenue Forecast by Application (2020-2025)
Table 126. Japan In Vitro Diagnostic/IVD Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. In Vitro Diagnostic/IVD Picture
Figure 2. Global In Vitro Diagnostic/IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global In Vitro Diagnostic/IVD Revenue Market Share by Type in 2019
Figure 4. Instruments Picture
Figure 5. Reagents Picture
Figure 6. In Vitro Diagnostic/IVD Revenue Market Share by Application in 2019
Figure 7. Diabetes Picture
Figure 8. Oncology Picture
Figure 9. Cardiology Picture
Figure 10. Nephrology Picture
Figure 11. Global In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2025) (USD Million)
Figure 12. Global In Vitro Diagnostic/IVD Market Size Share by Regions (2015-2025)
Figure 13. Global In Vitro Diagnostic/IVD Market Size Share by Regions in 2019
Figure 14. Global In Vitro Diagnostic/IVD Revenue Market Share by Regions (2020-2025)
Figure 15. North America In Vitro Diagnostic/IVD Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. Europe In Vitro Diagnostic/IVD Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific In Vitro Diagnostic/IVD Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. South America In Vitro Diagnostic/IVD Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. Middle East & Africa In Vitro Diagnostic/IVD Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. Global In Vitro Diagnostic/IVD Revenue Share by Players in 2019
Figure 21. Global Top 5 Players In Vitro Diagnostic/IVD Revenue Market Share in 2019
Figure 22. Top 10 Players In Vitro Diagnostic/IVD Revenue Market Share in Global Market in 2019
Figure 23. Global In Vitro Diagnostic/IVD Market Size (USD Million) by Type (2015-2025)
Figure 24. Global In Vitro Diagnostic/IVD Market Size Share by Application (2015-2025)
Figure 25. North America In Vitro Diagnostic/IVD Market Size Share by Countries (2015-2025)
Figure 26. North America In Vitro Diagnostic/IVD Market Size Share by Countries in 2019
Figure 27. United States In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 28. Canada In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 29. Mexico In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 30. Europe In Vitro Diagnostic/IVD Market Size Share by Countries (2015-2025)
Figure 31. Europe In Vitro Diagnostic/IVD Market Size Share by Countries in 2019
Figure 32. Germany In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 33. France In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 34. Russia In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 35. Italy In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Spain In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 37. UK In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 38. Asia In Vitro Diagnostic/IVD Market Size Share by Countries (2015-2025)
Figure 39. Asia In Vitro Diagnostic/IVD Market Size Share by Countries in 2019
Figure 40. China In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 41. Japan In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 42. Korea In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 43. India In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 44. Southeast Asia In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 45. South America In Vitro Diagnostic/IVD Market Size Share by Countries (2015-2025)
Figure 46. South America In Vitro Diagnostic/IVD Market Size Share by Countries in 2019
Figure 47. Brazil In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 48. Argentina In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 49. Middle East & Africa In Vitro Diagnostic/IVD Market Size Share by Countries (2015-2025)
Figure 50. Middle East & Africa In Vitro Diagnostic/IVD Market Size Share by Countries in 2019
Figure 51. Saudi Arabia In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 52. UAE In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 53. Egypt In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 54. South Africa In Vitro Diagnostic/IVD Market Size (USD Million) and Forecast (2015-2025)
Figure 55. Global In Vitro Diagnostic/IVD Revenue Share by Type (2015-2020)
Figure 56. Japan In Vitro Diagnostic/IVD Revenue Share by Type (2015-2020)
Figure 57. Global In Vitro Diagnostic/IVD Revenue Share by Application (2015-2020)
Figure 58. Japan In Vitro Diagnostic/IVD Revenue Share by Application (2015-2020)




Companies Mentioned
Roche Diagnostics (Switzerland)
Sysmex Corporation (Japan)
Abbott Laboratories (US)
Siemens Healthineers (Germany)
Bio-Rad Laboratories (US)
Danaher Corporation (US)
DiaSorin (Italy)
Johnson and Johnson (US)
Thermo Fisher Scientific (US)
bioMérieux (France)
Ortho Clinical Diagnostics (US)
Agilent Technologies (US)
QIAGEN (Germany)

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets